罗欣药业(002793.SZ)拟定增股票募资不超8.424亿元

Core Viewpoint - 罗欣药业 plans to issue A-shares to specific investors, aiming to raise up to RMB 842.4 million for various projects [1] Group 1: Fundraising Details - The company intends to issue shares to no more than 35 qualified investors, including legal entities, individuals, or other legitimate investment organizations [1] - The total amount of funds to be raised is capped at RMB 842.4 million, which includes the principal amount [1] Group 2: Use of Proceeds - The raised funds will be allocated to the following projects: innovative drug research and development, expansion and technical upgrades of raw material drug production, and supplementing working capital [1]